Detection of galectin-8 was significantly lower in invasive bladder tumors compared to superficial bladder cancer or normal urothelium, suggesting that galectin-8 loss is associated with more aggressive bladder cancer phenotypes [61]. This evidence concerns the gene LGALS8 and urinary bladder carcinoma.